Feasibility of remote interviews in assessing disease severity in patients with major depressive disorder: A pilot study
Neuropsychopharmacology Reports · 2024
DOI: 10.1002/npr2.12411 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Neuropsychopharmacology Reports, 2024. Verfasst von Tomiki Sumiyoshi und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Center of Neurology and Psychiatry, Tokyo, Japan. Hauptthemen laut MEDLINE: Major Depressive Disorder. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sumitomo Pharma Co., Ltd., Meiji Seika Pharma Co., Ltd., Otsuka Pharmaceutical Co., Ltd..
Abstract (Originalsprache)
Aim
Interview quality is an important factor in the success of clinical trials for major depressive disorder (MDD). There is a substantial need to establish a reliable, remote clinical assessment interview system that can replace traditional in‐person interviews.
Methods
We conducted a multicenter, randomized, unblinded, prospective, cross‐sectional study to assess the reliability of remote interviews in patients with MDD (UMIN000041839). Eligible patients with MDD underwent remote and in‐person sessions of the Montgomery‐Åsberg Depression Rating Scale (MADRS) assessment performed by different raters within 28 days of providing consent. Patients were randomized to a group first assessed using in‐person interviews and secondarily using remote interviews (in‐person‐first group) or a group first assessed by remote interviews and secondarily using in‐person interviews (remote‐first group). Nineteen trained people (15 clinical psychologists, 3 nurses, and 1 clinical laboratory technologist) performed interviews.
Results
Of 59 patients (in‐person‐first group, n = 32; remote‐first group, n = 27) who completed both remote and in‐person interviews, 51% ( n = 30) were women; the mean age was 41.6 years (range, 21–64 years). There was a strong association between remote and in‐person MADRS scores ( r = 0.891, kappa = 0.901). An overall intraclass correlation coefficient (ICC) of 0.886 (95% confidence interval, 0.877–0.952) indicated good consistency between MADRS scores in remote and in‐person interviews. The ICC decreased as the severity of depression increased.
Conclusion
Our results suggest remote interviews are a feasible alternative option to in‐person interviews in assessing symptom severity in MDD patients and could promote clinical trials in Japan.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Center of Neurology and Psychiatry, Tokyo, Japan.
- Ichigaya Himorogi Clinic, Tokyo, Japan.
- Hills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan.
- Psychiatry Department, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.
- Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan.
- Department of Psychosomatic & Psychiatric Medicine, Tokyo Women's Medical University Adachi Medical Center, Tokyo, Japan.
ORCID-Profile: Tomiki Sumiyoshi, Taishiro Kishimoto, Kazuyuki Nakagome
Förderung
- Sumitomo Pharma Co., Ltd.
- Meiji Seika Pharma Co., Ltd.
- Otsuka Pharmaceutical Co., Ltd.
- Shionogi & Co., Ltd.
- Takeda Pharmaceutical Company Limited
- Janssen Pharmaceutical K.K.
- Otsuka Pharmaceutical
- Takeda Pharmaceutical Company
Zitieren
APA
Sumiyoshi, T., Morio, Y., Kawashima, T., Tachimori, H., Hongo, S., Kishimoto, T., Watanabe, K., Otsubo, T., Oi, H., Nakagome, K., & Ishigooka, J. (2024). Feasibility of remote interviews in assessing disease severity in patients with major depressive disorder: A pilot study. Neuropsychopharmacology Reports. https://doi.org/10.1002/npr2.12411
Vancouver
Sumiyoshi T, Morio Y, Kawashima T, Tachimori H, Hongo S, Kishimoto T, et al. Feasibility of remote interviews in assessing disease severity in patients with major depressive disorder: A pilot study. Neuropsychopharmacology Reports. 2024. doi:10.1002/npr2.12411
BibTeX
@article{Sumiyoshi2024,
author = {Sumiyoshi, Tomiki and Morio, Yasunori and Kawashima, Takahiro and Tachimori, Hisateru and Hongo, Seiji and Kishimoto, Taishiro and Watanabe, Koichiro and Otsubo, Tempei and Oi, Hideki and Nakagome, Kazuyuki and Ishigooka, Jun},
title = {Feasibility of remote interviews in assessing disease severity in patients with major depressive disorder: A pilot study},
journal = {Neuropsychopharmacology Reports},
year = {2024},
doi = {10.1002/npr2.12411}
}
EUVIMED